Defiance Daily Target 2X Long NVO ETF

Defiance Daily Target 2X Long NVO ETF is a leveraged exchange-traded fund designed to provide daily investment results equal to two times the performance of Novo Nordisk A/S’s American Depositary Receipt. The fund uses derivatives such as swap agreements and listed options rather than investing directly in the underlying company, making it a synthetic, single-stock strategy centered on Novo Nordisk exposure. It is structured for short-term trading and daily rebalancing, with performance tied to one-day market movements rather than long-term holding periods. The fund primarily appeals to market participants seeking amplified, focused exposure to Novo Nordisk within the health care and pharmaceuticals segment. Defiance Daily Target 2X Long NVO ETF plays a specialized role in the market by offering a targeted leveraged instrument for accessing one of the most closely watched global drugmakers through the ETF wrapper.